Browsing: NovoNordisk

Novo-Nordisk stock (ISIN DK0062498333) is drawing attention on September 1, 2026 as the Danish pharmaceutical group rolls out its Wegovy weight-loss pill in Germany, the first European Union market to receive the oral version of its flagship obesity drug. According to a report by Reuters dated September 1, 2026, Novo-Nordisk executives previously indicated that the…